Obsessive-compulsive disorder (OCD) clinical presentation is remarkably diverse, and can vary both within and across patients over time. This variability in the phenotypic expression has led to the hypothesis that OCD is a heterogeneous disorder and that this heterogeneity obscures the findings of clinical, natural history and treatment response studies and complicates the search for vulnerability genes. A complete understanding of what comprises OCD and the underlying etiological mechanisms will require a dramatic change in how the disorder is conceptualized. In this review, several different approaches that may represent the first steps in this reconceptualization are discussed. These approaches include (1) narrowing the phenotype to identify categorically defined more homogeneous and mutually exclusive subtypes of OCD, (2) considering OC symptom dimensions as quantitative components of the more complex OCD phenotype and (3) broadening the phenotype to include other etiologically related conditions. A combined dimensional approach within distinctive subgroups is proposed as probably the most effective in helping to identify the heritable components of OCD. By identifying heritable components of OCD, it should be possible to find genes for these separate components. The review continues with the illustration of the possible role of some epigenetic risk and protective factors in the OCD presentation and the relevance of examining associated traits and/or endophenotypes to enhance our ability to understand the genetic basis of OCD. To conclude, we discuss the variability in treatment outcome and the significance of the development of specific pharmacological and/or behavioral based therapies tailored to each of these phenotypes. Molecular Psychiatry (2005) 10, 258-275.
Obsessive-compulsive disorder (OCD) is a chronic, neuropsychiatric disorder that affects approximately 2% of the world population and significantly interferes with social, family and work functioning. 1 OCD is characterized by intrusive unwanted thoughts, fears or images (obsessions) and/or ritualized behaviors or mental acts (compulsions), generally performed to relieve the anxiety and/or distress caused by the obsessions. 2 The DSM IV 2 criteria for OCD have been shown to be reliable and well replicated among different cultures. However, the current concept, adopted by DSM-IV 2 and ICD-10, 3 of defining OCD as a unitary nosological entity may be misleading. In fact, obsessive-compulsive (OC) symptoms are remarkably diverse, and the clinical presentation can vary both within and across patients over time. 4 This variability in the phenotypic expression has led to the hypothesis that OCD is a heterogeneous disorder and that this heterogeneity obscures the findings of clinical, natural history and treatment response studies and complicates the search for vulnerability genes.
Success in refining the measurement of OC phenotypes is likely to lead to greater clarity concerning course, treatment strategies and outcome. Likewise, a better description of clinical phenotypes should facilitate genetic, neurobiological, environmental and treatment response studies. In fact, dissecting the phenotype into less complex components may be an important tool for the identification of susceptibility genes for OCD.
The main objective of this paper is to summarize the available data describing the clinical heterogeneity of OCD and review the studies that suggest that this clinical heterogeneity may be due to an underlying genetic heterogeneity. Furthermore, different strategies (including both categorical and dimensional approaches) of phenotype description will be discussed. The review continues with the illustration of the possible role of some epigenetic risk and protective factors in the OCD presentation. Specifically, data regarding streptococcal infection and rheumatic fever (RF) (given recent findings suggesting their association with OCD) will be summarized. We hypothesize that these and other as yet unidentified epigenetic factors are likely to be etiologically important and that the illnesses currently identified as OCD are most likely the result of complex interactions between genes and environment over the course of brain development.
The paper proceeds with a discussion of the relevance of examining associated traits and/or endophenotypes for linkage and association studies and of the likelihood that they will enhance our ability to understand the genetic basis of OCD. The rationale for the use of endophenotypes, which are traits associated with specific conditions but not including any aspect of the clinical manifestation of the syndrome under study, is based on the assumption that the number of genes required to produce variations in OCD traits may be fewer than those involved in producing the OCD diagnosis. 5 In addition, these intermediate phenotypes could be less influenced by environmental factors and be a better way to define affected and nonaffected individuals in a given family.
To conclude, we discuss the variability in treatment outcome as additional evidence of OCD heterogeneity and propose a combined dimensional conceptualization within distinct subgroups as probably the most effective means of identifying the heritable components of OCD as well as new treatment strategies.
Brief overview of genetic studies of OCD
The results from twin and family studies suggest that transmission and expression of OCD and lesser phenotypes are genetically mediated. [6] [7] [8] Furthermore, there may be an 'OCD spectrum' of related disorders that share some of the same vulnerability genes. While the extent of this spectrum remains unknown, there are some compelling data supporting the genetic association between OCD and disorders such as Gilles de la Tourette syndrome (TS), body dysmorphic disorder (BDD) and grooming behaviors. 6, 9, 10 Additional studies also suggest (see below) that obsessivecompulsive personality disorder (OCPD), currently conceived as a personality disorder, is also potentially a condition within the OCD spectrum. 11 Patterns of transmission within families are consistent with genetic transmission, although segregation analyses of OCD family data 7, [12] [13] [14] have yielded divergent results. Some studies are consistent with a simple Mendelian mode of transmission, while others suggest a more complex pattern of transmission that may be due to multifactorial components that are likely present in the expression of OCD. 7 Molecular genetic research in OCD has been largely limited to candidate gene studies. 15 The majority of studies conducted to date have focused on genes important in the serotonin and dopaminergic neurotransmitter systems due to the efficacy of serotonin reuptake inhibitors (SRIs) and dopamine antagonists in the treatment of OCD patients. [16] [17] [18] In summary, even though the genetic transmission of OCD is indisputable, the mode of transmission and the genes involved are still unknown. A major difficulty in genetic studies of complex disorders such as OCD has been sample heterogeneity. Therefore, it is believed that the identification of subgroups that are genetically valid is extremely important for OCD research.
Strategies for identifying valid OCD phenotypes
Several strategies have been employed in the search for more homogeneous phenotypes, and some of these studies will be presented below.
The categorical approach: the identification of homogeneous and mutually exclusive subgroups The categorical approach describes specific clinical and phenomenological characteristics of OCD in order to identify those that may be associated with an independent pattern of inheritance. The rationale for this approach is that elucidation of specific homogeneous subgroups might lead to the identification of a subtype of OCD that is distinctively transmitted within families and might be due to unique genetic factors that could be more easily identified with genetic linkage studies.
Some clinical and phenomenological characteristics have been shown to be related to familial risk and thus could represent different OCD subtypes. Among these are age at onset of OC symptoms, comorbidity with tic disorders and higher frequencies of sensory phenomena associated with compulsions.
Early-onset OCD phenotype
Although DSM-IV and ICD-10 use the same diagnostic criteria for children and adults, recent studies have suggested that age at onset of OC symptoms is an important factor in subtyping OCD, and that children with OCD as well as adults with an early onset of their symptoms may represent a more etiologically homogeneous subset of patients. [19] [20] [21] [22] This hypothesis was emphasized in clinical studies reporting that OCD age of onset is bimodal. Before puberty, there is a peak among male patients. 19, 20, 23 During adolescence, there is an increase in the number of girls diagnosed with OCD, reaching a 1 : 1 sex ratio in adulthood. 24 As in adult patients, 22, 25 high rates of comorbidity are seen in children and adolescents with OCD, and some studies report that 90% of patients in their OCD samples had at least one other neuropsychiatric diagnosis. 26 Even though other disorders, such as depression, simple phobias, separation anxiety and disruptive behavior disorders, are also very frequent, 27 the association with tics is the most striking. In studies of children with OCD, it has been reported that 20-59% have tics. 28 Similarly, 48% of early-onset OCD patients presented tics or TS, compared to 10% of OCD subjects with a later onset. 21 Some of the most frequent findings described in early-onset patients (both children and adults) are presented in Table 1 .
In a recent study, Diniz et al 22 examined the relationship between comorbidity patterns and age at onset, as well as illness duration, in adult OCD patients. These investigators found that an earlier age at onset of OC symptoms was associated with tic disorders, whereas longer illness duration was associated with depressive disorder and social phobia. 22 There have been few studies incorporating age at onset into neurobiological investigations of OCD. Busatto et al, 34 using regional cerebral blood flow (rCBF) SPECT, found that early-onset patients showed decreased rCBF in the right thalamus, left anterior cingulate cortex and bilateral inferior prefrontal cortex, as well as increased rCBF in the right cerebellum. Moreover, OC symptom severity was positively correlated with left orbitofrontal rCBF in early-onset patients.
Studies with adult patients have suggested that an early age of onset may be a predictor of poor response to treatment with clomipramine or other SRIs, 21, 35, 36 although other studies found no such relationship. 37, 38 Age at onset also appears to be related to differential familial recurrence risk of OCD. 6, 7, 9 In a recent study of 106 families of children and adolescents with OCD, Rosario-Campos et al 32 studied 325 firstdegree family members of childhood and adolescent OCD probands and 140 first-degree relatives of control children and adolescents. The results from this study were consistent with earlier reports from families of adult OCD probands with early onset. The rates of OCD observed among first-degree relatives were significantly higher than those seen in family studies of adult OCD probands (see Table 2 ). The rate of OCD among case relatives was 25.2 times higher than the rate among control relatives. Other interesting findings were a significant positive correlation between the ages at onset of OCD in case probands and their affected relatives and a significantly higher rate of TS and tics among case relatives, when compared to control relatives (OR ¼ 7.8). Interestingly, although the recurrence risks among case relatives were high, only 57% of the probands had a positive family history of OCD or tics, reinforcing the hypothesis that OCD is in fact a genetically heterogeneous condition. Some cases are familial (associated or not to tics), and others have no family history.
To date, there have been no segregation analyses completed on data from early-onset OCD families. Similarly, there is a paucity of molecular studies performed with samples composed of individuals with early-onset OCD (see Table 5 ). One association study 39 found significant differences between OCD subjects and controls in genotype and allele frequencies of the A allele of the 5-HT2A receptor gene. A genome-wide linkage analysis 40 suggested evidence for linkage on chromosome 9p. The same group sequenced the LOD score peak region identified in this genome scan and found no evidence for a functional mutation in the SLC1A1 gene. 41 In sum, the early-onset phenotype is characterized by a male preponderance 24, 42 , a higher frequency of compulsions not preceded by obsessions, 19, 21 higher comorbidity with tics and TS 20, 28 and worse response to monotherapy treatment with clomipramine or SRI. 21, 35 Furthermore, the early-onset phenotype has been associated with increased familial loading for OCD. 6, 7, 30, 32 Taken together, these data suggest that the [45] [46] [47] [48] [49] [50] [51] but also higher rates of tics or TS in first-degree relatives of OCD patients 6,9,28,32 when compared to controls. These results suggest that at least some forms of OCD are etiologically related to TS and might therefore be variant expressions of the same genes that are important for the expression of tics. Table 3 presents the results from some studies describing the clinical features that characterize the tic-related OCD phenotype. For a more detailed review, see Miguel et al 52 .
Sensory phenomena as a component of the OCD phenotype Another way of approaching the psychopathology of OCD is the investigation of the subjective experiences that precede or accompany their compulsions. In many cases, these subjective experiences or feelings, defined as sensory phenomena, are responsible for significant psychosocial distress. First described in TS patients, sensory phenomena is a comprehensive term, inconsistently defined in the literature, explained in different ways by different authors. [66] [67] [68] [69] [70] [71] [72] Miguel et al 53 proposed to group these various descriptions of sensory phenomena into 'bodily sensations' (ie focal or generalized body sensations occurring before the patient performed the repetitive behaviors) and 'mental sensations' (ie general, uncomfortable feelings or perceptions occurring before or while the patient performs the repetitive behaviors).
The same authors compared the frequencies of sensory phenomena preceding the repetitive behaviors in patients with OCD without tics, TS without OCD and OCD plus TS. 44, 53 As expected, compared to the TS group, OCD patients reported lower frequency of sensory phenomena preceding their repetitive behaviors. Like the TS group, the OCD plus TS group reported significantly more intentional repetitive behaviors preceded by sensory phenomena when compared to the OCD group. Other studies have also reported a higher frequency of sensory phenomena in OCD patients with tics. 61, 62, 70 Similarly, Rosario-Campos et al 21 reported that these sensory phenomena were significantly more frequent in adult OCD patients with an early onset of their symptoms, independently of the presence of tic disorders, when compared to adults with a later onset.
In summary, these sensory phenomena are now believed to be an integral part of the OCD phenomenology 21, 44, 53, 62 and may help to characterize the phenotypic expression of OCD patients. Nevertheless, there have been, to date, no studies investigating the familiality of these sensory phenomena or whether they would identify different gene association patterns within OCD patients.
The dimensional approach
Categorizing OCD patients by their age at onset of OC symptoms and comorbidity with tics has led to some important observations regarding familiality and treatment response. Nevertheless, additional strategies are needed to further understand the clinical and etiological heterogeneity observed in these subsets of OCD patients. Quantitative measures of the phenotype may prove to be of even greater value, particularly for genetic studies.
Two main strategies have been used to better understand the dimensionality of the OC phenotypes, one using OC symptom dimensions and another using quantitative personality traits.
OCD symptom dimensions Baer 64 was the first to explore the possibility that the variability observed among OCD patients could be reduced into a smaller number of categories that occurred together more than would be expected to occur by chance. He reported the results of factor analyses of the 13 major categories of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) symptom checklist (SC) 73 in a sample of 107 OCD patients. Three factors accounting for 48% of the variance were identified. These factors/dimensions were characterized by symmetry and hoarding, 'contamination and cleaning' and 'pure obsessions'.
In an attempt to replicate Baer's work, Leckman et al 4 completed a factor analysis with Varimax rotation of the same 13 Y-BOCS symptom categories in a sample of 306 OCD patients. Four factors or dimensions, accounting for more than 60% of the variance, were identified. Factor I is characterized by aggressive, sexual, somatic and religious obsessions, as well as related compulsions. Factor II includes symmetry, ordering and counting, as well as arranging obsessions and compulsions. Factor III involves contamination obsessions and cleaning compulsions. Factor IV is characterized by hoarding obsessions and compulsions. Of interest is the fact that high scores on factors I and II were associated with a personal or family history of tics in these OCD patients.
To date, there have been 11 factor analysis studies published, assessing more than 2000 patients. 4, 63, 64, [74] [75] [76] [77] [78] [79] [80] [81] [82] In all of these studies, 3-5 OC factors or dimensions have been identified, accounting for almost 70% of the variance. 83 Additionally, there is a growing body of evidence from various fields suggesting that these OCD symptom dimensions are valid and reliable constructs. As noted above, the factors identified in all studies are fairly consistent 4, 63, 76 and temporally stable. 77 In addition, these factors have been shown to be correlated with a number of biometric variables 14, 79, 82, [84] [85] [86] as well as with treatment response. 63, 77, 85, 87, 89 Furthermore, recent neuroimaging studies have provided additional support for the validity of these factors; different patterns of activation have been observed for different OC symptom dimensions. 90 In contrast, initial volumetric MRI studies show only modest differences across symptom dimensions.
Alsobrook et al 14 were the first to use OC symptom dimensions in a family/genetic study. They reported that the relatives of OCD probands who had high scores on either the factor characterized by aggressive/sexual/religious obsessions and related compulsions or factors characterized by symmetry/ordering (factors I and II as described by Leckman et al 4 ) were twice as likely to have first-degree family members with OCD compared to individuals with low scores on these factors. 14 In a more recent study, 82 the familiality of OCD symptom dimensions was examined in a sample of TS affected sibpairs from the Tourette Syndrome Association International Consortium for Genetics (TSAICG). 91 Significant correlations were observed between sibpairs as well as mother-child pairs for the aggressive, sexual and religious obsessions and checking compulsions factor, and for the symmetry and ordering obsessions and compulsions factor. Furthermore, the results from segregation analyses in this sample were consistent with dominant major gene effects for the aggressive, sexual and religious obsessions and checking compulsions factor, and for the symmetry and ordering obsessions and compulsions factor, and recessive major gene effects for the contamination/cleaning factor and the hoarding obsessions and compulsions factor. It is not clear whether these results will generalize to individuals with OCD who do not have TS, but the inclusion of TS sibpairs is of heuristic value because the OC symptoms observed in these families generally have an early onset, and therefore are more likely to be etiologically homogeneous.
Using the same TSAICG data set, Zhang et al 86 analyzed genotypic data from a genome scan using the hoarding factor as a quantitative phenotype. Significant allele sharing was observed for markers at 4q34-35, 5q35.2-35.3 and 17q25. The 4q site is in proximity to D4S1625, the marker that was identified by TSAICG as being in a genomic region with suggestive linkage to the TS phenotype. The 17q site has also been implicated in some TS families. Thus, the 4p and 17q results could simply be coming from linkage to the TS phenotype and not represent a separate locus for hoarding; however, the chromosome 5 site has not been implicated in any other study of TS and might suggest a separate locus for hoarding.
A recent case-control study in patients with tics found a significant association between the long/long haplotype polymorphism of the promoter region of the serotonin transporter gene (5-HTTLPR) and high scores on the 'repeating/counting' factor, located on chromosome 17q11. 1-12. 79 In conclusion, the complex clinical presentation of OCD can be summarized using a few consistent and temporally stable symptom dimensions. These can be understood as a spectrum of potentially overlapping vulnerabilities that do not establish an absolute, qualitative break between 'normal' and 'abnormal', cutting across diagnostic boundaries. This characteristic of the dimensional approach is particularly important for genetic studies, in which family members presenting with OC symptoms below the threshold for a DSM-IV diagnosis should also be assessed and included in research studies. 6, 82 A dimensional approach is also not mutually exclusive of other methods, and may indeed encompass previous attempts of subdividing patients according to age at onset or comorbidity with tics. Indeed, the combined use of categorical and dimensional approaches is likely to offer the greatest promise. In fact, the use of quantitative traits may provide a powerful approach to detect the genetic susceptibility loci that contribute to OCD presentations. Thus far, this approach has provided especially promising leads with regard to the hoarding OC phenotype. Although the dimensional structure of OC symptoms is still imperfect, this quantitative approach to phenotypic traits has the potential to advance our understanding of OCD and may aid in the identification of more robust endophenotypes.
Quantitative personality traits related to OCD It has been suggested that some patients may be vulnerable to OCD because of their affective disposition (eg temperament), which could ultimately contribute to the expression of the condition. These individuals are 'abnormal' only in degree, not in kind. 92 For instance, a person who diverges to an extreme along the neuroticism dimension (which identifies those individuals who tend to have intense emotions) would be expected to respond with a dysphoric emotion such as anxiety or OC symptoms when facing a challenge that would not trouble a less affectively vulnerable individual. 92 Recent family data suggest that there may be some relationship between these personality dimensions and OCD. Samuels et al 11 reported that high neuroticism (measured by The Revised NEO Personality Inventory developed by Costa and McCrae 93 ), and OCPD were more frequent in relatives of OCD cases compared with relatives of controls.
Thus, these personality characteristics may share a common familial etiology with OCD. It is possible that neuroticism, OCPD and OCD are alternative expressions of the same underlying vulnerability. Each of these phenotypes may represent a different level of severity along a continuum, or additional factors may be necessary for differentiation into the specific clinical phenomena. Alternatively, these three phenotypes could represent distinct genetic entities, one being a direct expression of the genetic vulnerability and the other emerging secondarily.
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It is important to note that the results from molecular genetic studies suggest that there may be some genes that are associated with some of these quantitative traits. The low-activity allele of the promoter region of the serotonin transporter gene (5-HTTLPR) has been reported to be associated with neuroticism and harm avoidance in normal volunteers. 94, 95 In another study, carriers of the same allele exhibited higher scores for neuroticism and harm avoidance than noncarriers, although only within a subgroup of patients with avoidant, dependent and OCPD diagnosis and not among those with other DSM-IV personality disorders. 96 Broadening the OCD phenotype OCD and OCD spectrum disorders In contrast to disaggregating OCD into smaller quantitative components, another strategy that could enhance the probability of finding susceptibility genes for OCD would be the identification of other conditions that were etiologically related and due to the same underlying mechanisms. Thus, broadening the diagnostic boundaries could enhance the chance of detecting genes related to OCD. Several disorders have been proposed as part of an OCD spectrum of disorders because they have been observed more frequently among relatives of OCD probands when compared to controls (see Table 4 ).
Nestadt et al, 101 using the latent class analysis and data from previous studies of The Johns Hopkins OCD Family Study Group, identified two subgroups: one characterized by panic disorder/agoraphobia (PD/AG) and tic disorders (TD) and another characterized by generalized anxiety disorder (GAD), recurrent major depressive disorder (RMDD) and OCD spectrum disorders (eg body dysmorphic disorder, eating disorders and grooming behaviors). Relatives of probands in the second group were at greater risk for OCD and OCD-related comorbid diagnoses. Furthermore, age of onset was progressively lower for those subjects with more OCD-related comorbidity. The group with PD/AG and TD presented a later age of onset of OCD and tended to have lower familial loading.
Recently, Chacon et al 102 elaborated on some of these conclusions and suggested that TD should also be included in the OCD spectrum disorders group. The rationale for this was based on data from previous clinical studies 22, 65 indicating an association between TD and other OCD spectrum disorders such as body dysmorphic disorder and trichotillomania. Furthermore, there are consistent findings suggesting an association between TD and early OCD age of onset in the proband 21 and higher familial risk for OCD in their relatives. 6, 32 In addition, these authors speculated that one possible explanation for this divergence could be the fact that the presence of TS was an exclusionary criterion in the John Hopkins OCD Family Study. 7 The different phenotypes expressed in this subgroup could reflect the interaction of the same genetic vulnerability factors modified by life events or environmental factors, consistent with the concept of clinical heterogeneity. 103 The second subgroup would be characterized by the presence of separation anxiety and PD/AG and a lower genetic risk and later age of onset.
Additional data suggest that hypochondria, 104 attention-deficit/hyperactivity disorder 65 and eating disorders 105 should also be considered as part of the OCD spectrum disorders constellation. The proposed model is graphically represented in Figure 1 .
OCD and other syndromes
As discussed above, phenomenological, clinical and family/genetic studies have yielded data suggesting that a spectrum of behaviors is related to OCD and that there may be common etiological factors important for the expression of some components of these behaviors. To date, there have been few molecular genetic findings identifying specific susceptibility genes for these phenotypes (see Table 5 ). However, recent studies showing that OC symptoms may be associated with other syndromes could provide clues for the location of some susceptibility genes for OCD. For instance, some interesting findings have come from studies of idiopathic focal dystonia (IFD) and Prader-Willi syndrome (PWS). Cavallaro et al 100 reported the results of a family study with 76 IFD patients and 129 controls. The presence of OCD was higher in the patients with IFD compared to controls (20 vs 0.77%). Nearly all IFD patients with OCD showed poor insight and reduced egodystonia regarding OCD symptoms, which were long standing. These investigators also found a higher morbid risk for OCD but only among family members of probands of IFD plus OCD when compared to family members of probands of IFD without OCD and to controls. Since IFD is rare, the high frequency of OCD in IFD reported suggests that a subgroup of IFD (IFD/OCD subgroup) has a higher probability of sharing biological mechanisms for both IFD and OCD. A few different hereditary backgrounds have been suggested for several types of dystonia (mutations at DYT1, DYT6, DYT7 and DYT13-some of the genes involved in dystonia). Candidate genes for dystonia could be tested in OCD patients.
PWS is a genetic disorder caused by an abnormality in chromosome 15. Approximately 70% of cases result from a paternally derived deletion at 15(q11-q13), whereas a maternal disomy is found in 30% of cases. Interestingly, the disorder is manifested when the father is the parent transmitting the anomalous gene. 106 Some OC symptoms, as well as OCD, have been described in PWS populations. [106] [107] [108] Wigren and Hansen 108 reported that the compulsions found in PWS were more often related to insistence on sameness, external routines and repetition rituals. They also reported high comorbidity with trichotillomania and skin picking. A study by Dykens et al 109 found almost the same pattern of OC symptoms, using the Y-BOCS symptoms: hoarding, ordering and arranging, just right compulsions, concern with symmetry and exactness, and redoing things. Clarke et al 107 also found insistence on routines, hoarding and ordering objects and repetitive actions and speech, pointing to the lack of more typical OC symptoms such as cleaning, checking and counting rituals. Altogether, these data suggest that the mechanisms underlying compulsions in PWS may be somewhat different from typical OCD. State et al 110 compared subjects with PWS to subjects with PWSlike features but who lacked the PWS genotype (ie a phenocopy) and confirmed that OC symptoms were more frequent in the former group, suggesting that OC symptoms may be part of the phenotype related to deletions in chromosome 15.
Chromosome 15 has also been implicated in autism, 111 a disorder in which compulsive features have also been described. The most common chromosomal abnormality reported to be associated with autism is a duplication of the 15q11-13 regions, although deletions have also been described. Thus, chromosome 15 could be a target of investigation in the search for candidate regions of OCD genes. Hollander et al 112 investigated relatives of 176 autistic probands of 57 multiplex families and found that probands with high rates of repetitive behaviors were more likely to have one or both parents with OC symptoms or OCD than probands with low rates of repetitive behaviors.
In conclusion, broadening the diagnostic boundaries of OCD represents another heuristic approach to enhance the chance of detecting genes related to OCD. Several psychiatric disorders were proposed as part of an OCD spectrum of disorders because they have been observed more frequently among relatives of OCD probands than among controls (Table 4 ). In family members of probands with some neurologic disorders such as IFD, OCD has also been reported. These findings suggest that OCD may be better conceptualized from a genetic standpoint as a quantitative trait, whereby the same genes may predispose to a variety of phenotypes. In addition, genes found relevant to Obsessive-compulsive disorder phenotypes EC Miguel et al other neuropsychiatric disorders, such as those described above, could be targeted in future OCD molecular studies.
Molecular findings associated with specific OCD phenotypes As reported earlier, molecular studies in OCD have focused mostly on candidate genes from the serotonin and dopaminergic system. Table 5 describes several studies showing molecular findings associated with some of the subgroups presented above. Usually, initial results are received with great enthusiasm. However, most have not been successfully corroborated via replication.
Environmental factors
Complex traits are most likely to be generated by complex interactions of environmental and experiential factors with a number of genes and their products. Even pivotal regulatory proteins of cellular pathways and neurocircuits are most likely to have only a very modest impact, while noise from nongenetic mechanisms obstructs identification of relevant gene variants. Finally, epigenetic phenomena might also substantially contribute to the molecular biology of behavior.
118,119
Epigenetic risk and protective factors Twin studies of OCD have consistently indicated the presence of unique environmental factors associated with the expression of the syndrome. 120, 121 Limited data have been presented on a variety of risk factors including pre-and perinatal adverse events, sexspecific hormonal factors, pregnancy and birth, psychosocial stressors and postinfectious immunebased factors. Additional longitudinal twin and singleton studies are needed to explore developmental trajectories within distinct subgroups of patients and to determine whether significant new genetic and environmental effects and interactions emerge during the course of adolescence and adulthood.
For more than a quarter of a century, it has been believed that perinatal factors play a role in OCD. 122 There is some indication that perinatal difficulties might predispose to earlier onset of OCD in males 123 and be associated with chronic tic disorders. 124 For example, in one study of individuals with TS, delivery complications, especially forceps deliveries, were associated with OCD. 124 Similarly, fetal exposure to relatively high levels of caffeine, nicotine or alcohol also predicted OCD in these same TS probands. 124 As mentioned above, males are more frequently affected with early-onset OCD than are females. While this could be due to genetic mechanisms, frequent male-to-male transmission within families appears to rule out the presence of an X-linked vulnerability gene. This observation has led to the hypothesis that androgenic steroids during critical periods in fetal development may play a role in the later development of tic-related OCD. 125 It has also led investigators to test the efficacy of antiandrogenic agents in treating OCD. It is of interest that the selective androgen antagonist flutamide had a positive effect in one OCD þ TS patient. 125 This finding, however, was not replicated in a larger open study. 126 Another interesting observation is that the rates of OCD among new mothers is substantially higher than rates among the population and vary from 11 to 47%. [127] [128] [129] [130] [131] Most of these cases begin during late pregnancy or a few days to 2 weeks after delivery and involve intrusive worries of the mother doing harm to the newborn. Indeed, there are even anecdotal reports that new fathers may also be at increased risk. 132 The neurobiological basis for this phenomenon remains in doubt. One tenable hypothesis is that these changes involve possible alterations in the central oxytocin and serotonergic pathways. 133, 134 Others have speculated that the postpartum period may be a normal period of heightened sensitivity to threat that, even among normal parents, has features of OCD. 135 The role of recent life events in influencing the onset and course of psychiatric disorders has been widely examined, and OCD has long been identified as a 'stress-sensitive' condition. However, only a few studies have investigated the occurrence of stressful or potentially triggering events in the history of individuals with OCD. [127] [128] [129] 131, 136, 137 Frequently reported precipitants include a recent move, sexual or marital problems and the illness or death of a near relative. [127] [128] [129] However, these studies have methodological weaknesses such as assessment of event occurrence without reliable and valid schedules, investigation of ill-defined premorbid study periods and absence of comparison groups. Nevertheless, most controlled studies have shown similar effects. 136, 137 Preliminary work also suggests a relevant relationship between the expression of symptoms of OCD and post-traumatic stress disorder (PTSD). For instance, Gershuny et al, 138 in a case series, reported that symptoms of OCD and PTSD were connected such that decreases in OCD-specific symptoms related to increases in PTSD-specific symptoms, and increases in OCD-specific symptoms related to decreases in PTSD-specific symptoms with important clinical implications.
138,139
Streptococcal infection, RF and the impact on future studies Based on reports of a higher prevalence of OCD in patients with Sydenham's chorea (SC, the neurological manifestation of RF), a number of studies were undertaken and the results suggest a possible relationship between streptococcus infection and OCD. 140 Additional studies reported a higher prevalence of OCD and TS in RF, even without SC, both in active 141, 142 and nonactive 143 phases. Furthermore, familial aggregation of OCD/TS has been described in relatives of RF cases (Hounie et al, personal communication).
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Given these findings, Swedo 140 proposed that there is a subgroup of prepubertal children, who, after exposure to streptococcal infection, did not develop RF but instead had an abrupt onset of OCD and TS symptoms. Swedo 140 referred to this group of children as Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS). The hypothesized mechanism underlying the relationship between streptococcal infection, RF and the OCD spectrum manifestations is the molecular mimicry between bacteria and host. This assumption has been widely supported by several studies showing higher levels of autoantibodies in OCD patients. 144 However, the sole presence of autoantibodies is not sufficient to explain the hypothetic symptom induction. Indeed, there are several unanswered questions about the connection between infection and neuropsychiatric symptoms. In rheumatic heart disease, crossreactive antibodies binding to streptococcal M proteins and to myosin have been identified. The same has not been demonstrated in SC or PANDAS patients. In addition, the presence of T cells at the site of damaged cardiac valves may explain the immune mechanism in rheumatic carditis, 145 although nothing similar has been demonstrated in SC. Crossreactivity has been found between N-acetyl-glucosamine (a streptococcal antigen) and lysoganglioside (a transmembrane molecule highly enriched in the CNS) using SC monoclonal antibodies. 146 However, it is still unclear how antibodies could cross the blood-brain barrier. The selective permeability of the blood-brain barrier presumably protects the brain from immunological insult. However, it has been demonstrated that antibody access into the brain can occur when immune-regulatory substances, such as cytokines or activated B or T cells, disrupt the barrier.
To further explore the genetics of this possible association between the immune system response and OCD/TS, studies focusing on the human leucocyte antigen (HLA) alleles, which are related to autoimmune susceptibility, have been conducted. Different populations have exhibited associations between RF and different HLA genotypes, such as HLA-DR6, DR7 and DQB1. 147, 148 There are several other associations, and data suggest that these might be related to clinical manifestations of RF. 149 To date, very few studies examining the relation between HLA and OCD have been published and the results have been inconclusive. In early studies, the presence of the D8/17 B cell marker, claimed as a non-HLA RF marker, was reported to be increased in OCD/TS and PANDAS patients. 140 However, these early findings have not been consistently replicated, and there is now considerable controversy regarding this relationship. 150, 151 Finally, one recent study 152 found an association between a variant in the myelin oligodendrocyte glycoprotein (MOG) gene, a component of the myelin sheath, and OCD. The authors suggested that the potentially autoimmune demyelinating role of this molecule, as a target autoantigen, could hypothetically be as an inductor of OCD, via demyelination in the frontal lobe or in other neuroanatomical regions. 152 The complexity of this model, in which a true autoimmune mechanism would be causing OCD, as well as the lack of evidence supporting it, argues for further studies.
It was initially proposed that exposure to streptococcus represented an 'environmental cause' of OCD and related disorders. 140 However, this does not appear to be the case, given that familial aggregation for OCD/TS has been described in relatives of PANDAS probands. 153 The rate of OCD found in relatives of OCD triggered by streptococcal infection cases (PANDAS/OCD) was the same as that found for OCD in relatives of children with OCD. It has been proposed that early-onset OCD shares underlying mechanisms with OCD triggered by streptococcal infections. On the other hand, it is also possible that, given the high frequency of exposure to streptococcus of prepubertal children, the reported association between OCD and exposure to streptococcus could be spurious. The same may be true for TS.
In summary, it has been demonstrated that there is an association between OCD/TS and streptococcal infections with and without RF (Table 6 ). However, it is not currently known if PANDAS, OCD, TS, RF and SC result from common susceptibility genes and, if so, what the common pathophysiological mechanisms might be. More work is needed and future research should focus on the role of functional cytokine polymorphisms and autoimmune mechanisms in the manifestation of OCD and related disorders in RF and PANDAS patients. If some of these polymorphisms are related to the manifestation of OCD, it would allow future studies to examine the impact of specific environmental factors involved in these disorders. Furthermore, establishing the role of streptococcal infections, if any, in the genesis of some neuropsychiatric disorders should allow clinicians to develop adequate treatments and preventive strategies for this subgroup of patients.
Endophenotypes
Another approach to enhance the discriminative capacity of linkage and association studies for understanding the genetic basis of OCD would be to identify endophenotypes associated with OCD. Endophenotypes can include neurophysiological, biochemical, endocrinological, neuropsychological, cognitive and neuroimaging (neuroanatomical) phenotypes. 5 Very little work has been carried out to identify endophenotypes for OCD, with the possible exception of structural and functional neuroimaging studies.
Neuroimaging as a useful tool for identifying OCD endophenotypes This section extends previous writings on this topic by Rauch and co-workers. 154, 155 To date, neuroimaging research has been highly influential in advancing neurobiological models of OCD (see Saxena and Rauch 156 ). Looking forward, however, there is as yet untapped potential for utilizing these methods to facilitate advances in genetic research. As illustrated in the earlier sections of this review, phenotypic characterization is an absolutely critical element of genetic studies. Perhaps, particularly in the area of psychiatric genetics, there has been increasing interest in the possibility of establishing endophenotypes (sometimes called extended phenotypes) that could serve as objectively derived, quantitative phenotypic parameters for use in genetic studies.
'Endophenotypes' are also defined as 'measurable components unseen by the unaided eye along the pathway between disease and distal genotype'. 5 Brain imaging measures have attributes that are well suited to this enterprise, enabling both objective and quantitative characterization of study participants. Perhaps more importantly, structural, functional and neurochemical brain measures promise to provide information that is truly mediating and intermediate between genes and corresponding clinical phenotypes. Explicitly, the premise is that a given gene or genetic profile will more directly correspond to a particular neural profile, which then in turn will more directly correspond to a clinical/behavioral phenotype (see Kosslyn and Plomin 157 and Gottesman and Gould). 5 That is, whereas there exist a range of divergent and convergent correspondences between genes and behavior, identifying the mediating neural profile will help to clarify these correspondences.
To elaborate, the challenge of delineating the genetics of OCD would be greatly simplified if there were a direct correspondence between a single gene and the categorical designation of meeting clinical diagnostic criteria for the disorder. However, as noted above, the case for OCD (and most other psychiatric disorders) is certainly not so simple. Consequently, it has been appealing to attempt to disaggregate the OCD phenotype into dimensions that might have a more direct correspondence to various genes. One way by which neuroimaging can assist in this process is to validate the supposition that a given phenotypic dimension or attribute directly corresponds to a specific neural profile, or in some cases to highlight where convergences or divergences from neural profile to clinical phenotype exist. In fact, if it can be shown via neuroimaging that a dimensional scheme for characterizing clinical OCD phenotypes maps well on to discrete, specific, corresponding neural profiles, then this would lend credence to using such a dimensional scheme for characterizing phenotypic variance within an OCD sample, and potentially mitigate the need to actually acquire brain imaging information as part of future genetic studies.
Here it is noteworthy that several imaging studies have been performed to test hypotheses regarding differences in brain function between categorically defined subsets of OCD subjects, including studies of patients with/without comorbid major depression, 158 early/later onset of OCD, 159 or pure presentations of washing vs checking 160 or hoarding. 161 Few studies to date, however, have sought to establish neural profiles that quantitatively covary with the prominence/severity of factor analytically derived symptom dimensions in OCD. 90 This approach has been recently employed in a recent study. Mataix-cols et al 162 used a symptom provocation paradigm with functional magnetic resonance imaging to investigate the neural correlates of washing, checking and hoarding symptom dimensions in OCD, and found a distinct pattern of activation associated with each symptom dimension. Patients demonstrated significantly greater activation than controls in bilateral ventromedial prefrontal regions and right caudate nucleus (washing); putamen/globus pallidus, thalamus and dorsal cortical areas (checking); left precentral gyrus and right orbitofrontal cortex (hoarding). Based on these findings, the authors propose that OCD could be better understood as a spectrum of multiple potentially overlapping syndromes that are likely to be continuous with 'normal' worries and extend beyond the traditional nosologic boundaries of OCD. However, in a separate volumetric study from Barcelona, few if any differences were observed. 163 Such preliminary data foreshadow the type of neuroimaging studies that need to be performed in order to validate current dimensional approaches as powerful surrogate indices of neural profiles, or conversely to confirm these brain imaging measures as robust biomarkers of the dimensional phenotypes. In this regard, it is important to emphasize that neuroimaging research could help to refine how the clinical phenotypes are characterized, so as to optimize concordance between clinical phenotypic designations and mediating neural profiles.
Nonetheless, it may turn out that sufficient unexplained variance exists between clinical subphenotypes and neural profiles that it would be most powerful to rely directly on neuroimaging measures as endophenotypes for genetic studies of OCD. Major drawbacks of such an approach include high cost (B$500-5000 per subject for various imaging measures) as well as increased subject burden (eg time, discomfort, and in some cases radiation exposure). Alternative indices of brain function (eg neuropsychological tests, evoked potentials, endocrine measures) might also be considered for use as endophenotypes in genetic studies. However, in general, these are cruder, less direct measures of brain function than can be provided by contemporary imaging methods. Whereas brain imaging measures have been referred to generically up to this point, there are profound issues to consider regarding which measures might actually be of use in genetic studies. As genotypes per se are lasting, relatively static, parameters, the ideal endophenotypes should likewise be temporally stable as trait markers. This is no small challenge, as essentially all measures of brain structure, function and chemistry are dynamic over the human lifetime. In particular, measures of regional brain activity are relatively state dependent.
Therefore, in order to develop brain imaging measures as useful phenotypes for genetic research, it would be important to demonstrate test/retest reliability, to standardize state variables during acquisition and to consider characterizing individuals against a normative trajectory to control for age/stage of development and sex, as well as possibly salient environmental factors (eg years of education).
A vast range of different brain imaging measures remains feasible as candidates for characterizing OCD phenotypes. These include (1) structural indices such as regional volumes, (2) functional indices such as regional metabolism at rest or regional brain activation during standardized behavioral tasks, (3) regional concentrations of neurochemical or metabolic products, such as n-acetyl aspartate, choline or glutamate and (4) regional indices of receptor binding potentials. It is a daunting task to explore this parameter space by brute force alone. The most rational starting point is to consider those measures and those brain elements for which between-group differences (OCD vs normal control subjects) have already been reliably found. This approach directs us to a circuit comprised of the orbitofrontal cortex, anterior cingulate cortex, striatum and thalamus. However, findings of structural abnormalities within these regions have been inconsistent, and functional abnormalities within this circuitry have largely been shown to resolve with successful treatment. Therefore, much work remains to be carried out if we are to identify brain imaging indices that can be readily leveraged as endophenotypes for the genetic study of OCD.
Finally, brain imaging can also be used to investigate the neural correlates of functional genetic polymorphisms. 164 That is, once candidate genes have been identified for OCD vulnerability, brain imaging studies can be used to delineate the structural, functional and neurochemical consequences of such genotypes. Hariri et al 165 have provided a pioneering example of such an approach, by illustrating differential brain activation profiles in subjects with one vs two copies of the short allele of the serotonin transporter (5-HTT) promoter polymorphism, which has been associated with reduced 5-HTT expression and function. This is a particularly germane example, given the central role of serotonin in the pharmacological treatment of OCD, and prevailing questions about the role of this transmitter system in OCD pathophysiology.
Treatment implications
Variability in treatment outcome of OCD consists of additional evidence supporting the notion that OCD is heterogeneous. Although the underlying causative process may not be addressed by pharmacotherapy, it might be useful to examine whether specific OCD phenotypes respond differently to drug treatments and whether polymorphisms associated with the mechanism of action of specific drugs may be in fact vulnerability genes related to the disorder. Given the possible multifactorial pathogenesis of OCD, these polymorphic genes could influence at least a small part of the phenotypic variance. Finally, genes associated with susceptibility to OCD might represent possible targets for future drug development. Several studies have searched for phenotypic features that could predict treatment response in OCD. Table 7 describes some phenotypic features that were reported as predictive of worse treatment response in OCD. Most of these variables were not replicated in subsequent studies. One of the most cited papers in this area, 166 however, provided Table 2 , some molecular studies support the involvement of the dopaminergic system in this OCD subtype. 113, 114 In addition, based on the efficacy of SRIs in OCD, polymorphisms in the promoter region of the serotonin transporter have been studied in OCD pedigrees. 18, 177, 178 However, no differences in SRI responses were found among the different genotypes studied. 178 In sum, the data on phenotypic features and knowledge of candidate genes that could predict treatment response in OCD are still very preliminary and represent additional evidence that a better definition of the OCD phenotype is needed. Future studies attempting to identify the pharmacogenetic targets that mediate antiobsessive effects on key neuronal functions may provide a theoretical foundation for important changes in the antiobsessive paradigm (today modeled based on specific actions of antidepressants). 179 
Conclusions and future studies
Many studies have provided strong evidence that OCD is clinically heterogeneous and that this clinical heterogeneity is likely due to etiologic heterogeneity. Gaining a complete understanding of what comprises OCD and the underlying etiological mechanisms will require a dramatic change in how the disorder is conceptualized. This is also probably true for all psychiatric disorders. In this review, several different approaches that may represent the first steps in this reconceptualization were discussed. These approaches include (1) narrowing the phenotype to identify categorically defined more homogeneous and mutually exclusive subtypes of OCD, (2) considering OC symptom dimensions as quantitative components of the more complex OCD phenotype and (3) broadening the phenotype to include other etiologically related conditions.
A combined dimensional approach within distinctive subgroups may be the most effective in helping identify the heritable components of OCD. In contrast to the categorical approach, factors or dimensions are not mutually exclusive. Therefore, each patient can exhibit one or more symptom dimensions at any given time. 4, 85 These symptom dimensions may cut across traditional diagnostic boundaries and thus could provide a more powerful approach for the detection of genetic susceptibility loci that contribute to OCD behaviors. However, to appreciate fully these quantitative dimensions, it is important that future studies examine the relationship between these dimensions and the clinical and phenomenological variables, such as tic-related vs non-tic-related OCD and early vs late-onset OCD, that suggest the existence of different subtypes of OCD.
If these dimensional quantitative phenotypes are to be used in subsequent molecular genetic studies, it is also imperative to determine which ones are heritable and transmitted within families. Once heritable components are identified, they could prove to be extremely beneficial in genetic linkage studies and other molecular genetic research.
New instruments capable of documenting this OCD dimensionality as well as specific aspects of the clinical presentation need to be developed. Progress has been made with respect to the assessment of OC symptom dimensions. A new instrument that incorporates Y-BOCS and adds additional items to better define these dimensions has been developed. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) has been piloted and the results of initial psychometric analyses are promising. 180 Furthermore, another instrument has been developed for the assessment of sensory phenomena: the University of Sao Paulo Sensory Phenomena Scale (USP-SPS); a validation study is currently underway.
The ultimate goal is to delineate heritable OCD phenotypes that will facilitate the identification of susceptibility loci important for the manifestation of these behaviors. Recent genetic studies have been unsuccessful in identifying the susceptibility genes for OCD or the most likely mode of transmission of the disorder. This is probably because OCD is an etiologically heterogeneous disorder. By identifying heritable components of OCD, it should be possible to find genes for these separate components. It is expected that different susceptibility genes would predispose to the different components of behavior.
In addition to the efforts of identifying the genes involved in the etiology and expression of OCD, future studies are also needed to provide more efficient tools for the investigation of the environmental and cultural factors involved in the expression of these different phenotypes. Likewise, new brainbased markers, including brain imaging profiles, are expected to provide endophenotypes for candidate gene studies, which may also be helpful in clarifying the genetic heterogeneity of OCD.
Finally, it is also hoped that the identification of more homogeneous OCD phenotypes will facilitate the development of new treatment strategies. The characterization of the pathophysiological mechanisms of OCD components could contribute to the development of specific pharmacological and behavioral therapies tailored to each of these phenotypes. A cure might one day be defined as specific treatment or prevention of an identifiable combination of genetic variation and environmental events 179 
